SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-501878"
 

Search: onr:"swepub:oai:DiVA.org:uu-501878" > Pharmacometric mode...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Pharmacometric modeling of drug adverse effects : an application of mixture models in schizophrenia spectrum disorder patients treated with clozapine

Albitar, Orwa (author)
Univ Sains Malaysia, Sch Pharmaceut Sci, Gelugor 11800, Penang, Malaysia.
Ghadzi, Siti Maisharah Sheikh (author)
Univ Sains Malaysia, Sch Pharmaceut Sci, Gelugor 11800, Penang, Malaysia.
Harun, Sabariah Noor (author)
Univ Sains Malaysia, Sch Pharmaceut Sci, Gelugor 11800, Penang, Malaysia.
show more...
Ahmad, Siti Nor Aizah (author)
Minist Hlth Malaysia, Hosp Pulau Pinang, Psychiat Dept, Jalan Residensi, Georgetown 10460, Malaysia.
Kjellsson, Maria C., docent, 1975- (author)
Uppsala universitet,Institutionen för farmaci
show less...
Univ Sains Malaysia, Sch Pharmaceut Sci, Gelugor 11800, Penang, Malaysia Minist Hlth Malaysia, Hosp Pulau Pinang, Psychiat Dept, Jalan Residensi, Georgetown 10460, Malaysia. (creator_code:org_t)
2022-11-15
2023
English.
In: Journal of Pharmacokinetics and Pharmacodynamics. - : Springer Nature. - 1567-567X .- 1573-8744. ; 50:1, s. 21-31
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Clozapine has superior efficacy to other antipsychotics yet is underutilized due to its adverse effects, such as neutropenia, weight gain, and tachycardia. The current investigation aimed to introduce a pharmacometric approach to simultaneously model drug adverse effects, with examples from schizophrenia spectrum patients receiving clozapine. The adverse drug effects were represented as a function of time by incorporating a mixture model to describe individual susceptibility to the adverse effects. Applications of the proposed method were presented by analyzing retrospective data from patients’ medical records in Psychiatric Clinic, Penang General Hospital. Tachycardia, weight gain, and absolute neutrophils count (ANC) decrease were best described by an offset, a piecewise linear, and a transient surge function, respectively. 42.9% of the patients had all the adverse effects, including weight gain (0.01 kg/m2 increase every week over a baseline of 24.7 kg/m2 until stabilizing at 279 weeks), ANC decrease (20% decrease from 4540 cells/µL week 12-20.8), and tachycardia (14% constant increase over a baseline of 87.9 bpm for a clozapine maintenance dose of 450 mg daily). 32.5% of the patients had only tachycardia, while the remaining 24.6% had none of the adverse effects. A new pharmacometric approach was proposed to describe adverse drug effects with examples of clozapine-induced weight gain, ANC drop, and tachycardia. The current approach described the longitudinal time changes of continuous data while assessing patient susceptibility. Furthermore, the model revealed the possible co-existence of ANC drop and weight gain; thus, neutrophil monitoring might predict future changes in body weight.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Farmaceutiska vetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Pharmaceutical Sciences (hsv//eng)

Keyword

Clozapine
Adverse effects
Mixture model
Pharmacometrics
Disease progression

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view